Evidence map›Paper›PMID 20308428›Full record

ArticleThe Journal of cell biology2010

The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1.

Robert J Cain, Bart Vanhaesebroeck, Anne J Ridley

Open access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 118 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. mBio · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Targeting PI3K/Akt signal transduction for cancer therapy.Signal transduction and targeted therapy · 2021
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Robert J CainRandall Division of Cell and Molecular Biophysics, King's College London, London SE1 1UL, England, UK.
Bart Vanhaesebroeck
Anne J Ridley
King's College London · GBQueen Mary University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/C505659/1Biotechnology and Biological Sciences Research Council BB/C505659/2Cancer Research UK
6 · The paper itself

Abstract

Endothelial cell-cell junctions control efflux of small molecules and leukocyte transendothelial migration (TEM) between blood and tissues. Inhibitors of phosphoinositide 3-kinases (PI3Ks) increase endothelial barrier function, but the roles of different PI3K isoforms have not been addressed. In this study, we determine the contribution of each of the four class I PI3K isoforms (p110alpha, -beta, -gamma, and -delta) to endothelial permeability and leukocyte TEM. We find that depletion of p110alpha but not other p110 isoforms decreases TNF-induced endothelial permeability, Tyr phosphorylation of the adherens junction protein vascular endothelial cadherin (VE-cadherin), and leukocyte TEM. p110alpha selectively mediates activation of the Tyr kinase Pyk2 and GTPase Rac1 to regulate barrier function. Additionally, p110alpha mediates the association of VE-cadherin with Pyk2, the Rac guanine nucleotide exchange factor Tiam-1 and the p85 regulatory subunit of PI3K. We propose that p110alpha regulates endothelial barrier function by inducing the formation of a VE-cadherin-associated protein complex that coordinates changes to adherens junctions with the actin cytoskeleton.

Indexed as

Adherens JunctionsCapillary PermeabilityCells, CulturedEndothelial CellsFocal Adhesion Kinase 2HumansIsoenzymesPhosphatidylinositol 3-Kinasesrac1 GTP-Binding ProteinTumor Necrosis Factor-alphaFocal Adhesion Kinase 2IsoenzymesPhosphatidylinositol 3-Kinasesrac1 GTP-Binding ProteinRAC1 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID20308428
PMCPMC2845076
OpenAlexW2076548587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.